Skip to main content
. 2022 Feb 9;10:832059. doi: 10.3389/fbioe.2022.832059

FIGURE 3.

FIGURE 3

(A) Timeline on patent expirations of reference products in European Medicines Agency; EMA (Moorkens et al., 2020) and U.S. Food and Drug Administration; USFDA (Derbyshire and Shina, 2019), publications on analytical similarity studies for biosimilars under (B) mAbs, and (C) non-mAbs.